BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 33737453)

  • 1. Anti-interleukin 1 agents for the treatment of recurrent pericarditis: a systematic review and meta-analysis.
    Imazio M; Andreis A; Piroli F; Lazaros G; Gattorno M; Lewinter M; Klein AL; Brucato A
    Heart; 2021 Jul; 107(15):1240-1245. PubMed ID: 33737453
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacologic treatment of acute and recurrent pericarditis: a systematic review and meta-analysis of controlled clinical trials.
    Avondo S; Andreis A; Casula M; Biondi-Zoccai G; Imazio M
    Panminerva Med; 2021 Sep; 63(3):314-323. PubMed ID: 34738773
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rilonacept and Anakinra in Recurrent Pericarditis: A Systematic Review and Meta-Analysis.
    Affas ZR; Rasool BQ; Sebastian SA; Affas RS; Mohamadtahr SK; Saoor NH; Mohammad AN; Saoor GH; Husain BA; Touza R; Touza G; Amen S; Nazzaro W
    Cureus; 2022 Nov; 14(11):e31226. PubMed ID: 36505131
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of Anakinra on Recurrent Pericarditis Among Patients With Colchicine Resistance and Corticosteroid Dependence: The AIRTRIP Randomized Clinical Trial.
    Brucato A; Imazio M; Gattorno M; Lazaros G; Maestroni S; Carraro M; Finetti M; Cumetti D; Carobbio A; Ruperto N; Marcolongo R; Lorini M; Rimini A; Valenti A; Erre GL; Sormani MP; Belli R; Gaita F; Martini A
    JAMA; 2016 Nov; 316(18):1906-1912. PubMed ID: 27825009
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Failure of anti Interleukin-1 β monoclonal antibody in the treatment of recurrent pericarditis in two children.
    Signa S; D'Alessandro M; Consolini R; Miniaci A; Bustaffa M; Longo C; Tosca MA; Bizzi M; Caorsi R; Mendonça LO; Pession A; Ravelli A; Gattorno M
    Pediatr Rheumatol Online J; 2020 Jun; 18(1):51. PubMed ID: 32546242
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interventions for reducing inflammation in familial Mediterranean fever.
    Yin X; Tian F; Wu B; Xu T
    Cochrane Database Syst Rev; 2022 Mar; 3(3):CD010893. PubMed ID: 35349164
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interventions for reducing inflammation in familial Mediterranean fever.
    Wu B; Xu T; Li Y; Yin X
    Cochrane Database Syst Rev; 2018 Oct; 10(10):CD010893. PubMed ID: 30338514
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anakinra for corticosteroid-dependent and colchicine-resistant pericarditis: The IRAP (International Registry of Anakinra for Pericarditis) study.
    Imazio M; Andreis A; De Ferrari GM; Cremer PC; Mardigyan V; Maestroni S; Luis SA; Lopalco G; Emmi G; Lotan D; Marcolongo R; Lazaros G; De Biasio M; Cantarini L; Dagna L; Cercek AC; Pivetta E; Varma B; Berkson L; Tombetti E; Iannone F; Prisco D; Caforio ALP; Vassilopoulos D; Tousoulis D; De Luca G; Giustetto C; Rinaldi M; Oh JK; Klein AL; Brucato A; Adler Y
    Eur J Prev Cardiol; 2020 Jun; 27(9):956-964. PubMed ID: 31610707
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rilonacept: A Newly Approved Treatment for Recurrent Pericarditis.
    Schwier NC
    Ann Pharmacother; 2022 May; 56(5):572-581. PubMed ID: 34459270
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of colchicine in addition to anakinra in patients with recurrent pericarditis.
    Collini V; Andreis A; De Biasio M; De Martino M; Isola M; Croatto N; Lepre V; Cantarini L; Merlo M; Sinagra G; Abbate A; Lazaros G; Brucato A; Klein AL; Imazio M
    Open Heart; 2024 Mar; 11(1):. PubMed ID: 38490715
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rilonacept for the treatment of recurrent pericarditis.
    Fava AM; Reyaldeen R; Lo Presti S; Goyal A; Akintoye E; Hughes D; Klein AL
    Expert Opin Biol Ther; 2022 Jan; 22(1):7-16. PubMed ID: 34757872
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Colchicine for pericarditis.
    Alabed S; Cabello JB; Irving GJ; Qintar M; Burls A
    Cochrane Database Syst Rev; 2014 Aug; 2014(8):CD010652. PubMed ID: 25164988
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-interleukin-1 agents for pericarditis: a primer for cardiologists.
    Imazio M; Lazaros G; Gattorno M; LeWinter M; Abbate A; Brucato A; Klein A
    Eur Heart J; 2022 Aug; 43(31):2946-2957. PubMed ID: 34528670
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effectiveness of colchicine for the prevention of recurrent pericarditis and post-pericardiotomy syndrome: an updated meta-analysis of randomized clinical data.
    Agarwal SK; Vallurupalli S; Uretsky BF; Hakeem A
    Eur Heart J Cardiovasc Pharmacother; 2015 Apr; 1(2):117-25. PubMed ID: 27533981
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A systematic review and meta-analysis of randomized controlled trials evaluating pharmacologic therapies for acute and recurrent pericarditis.
    Melendo-Viu M; Marchán-Lopez Á; Guarch CJ; Roubín SR; Abu-Assi E; Meneses RT; Ynsaurriaga FA; Hernandez AV; Bueno H
    Trends Cardiovasc Med; 2023 Jul; 33(5):319-326. PubMed ID: 35131416
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transition to rilonacept monotherapy from oral therapies in patients with recurrent pericarditis.
    Brucato A; Wheeler A; Luis SA; Abbate A; Cremer PC; Zou L; Insalaco A; Lewinter M; Lewis BS; Lin D; Nicholls S; Pancrazi M; Klein AL; Imazio M; Paolini JF
    Heart; 2023 Jan; 109(4):297-304. PubMed ID: 36316102
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel Pharmacotherapies for Recurrent Pericarditis: Current Options in 2020.
    Tombetti E; Mulè A; Tamanini S; Matteucci L; Negro E; Brucato A; Carnovale C
    Curr Cardiol Rep; 2020 Jun; 22(8):59. PubMed ID: 32562029
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Brief Overview of Recurrent Pericarditis Management and the Potential of Rilonacept as a New Therapeutic Option.
    Gupta M; Kaul S; Velazquez GR; Bandyopadhyay D; Fonarow GC; Klein A; Ghosh RK
    Am J Cardiovasc Drugs; 2022 Jan; 22(1):27-33. PubMed ID: 34008144
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and safety of colchicine for pericarditis prevention. Systematic review and meta-analysis.
    Imazio M; Brucato A; Forno D; Ferro S; Belli R; Trinchero R; Adler Y
    Heart; 2012 Jul; 98(14):1078-82. PubMed ID: 22442198
    [TBL] [Abstract][Full Text] [Related]  

  • 20. RHAPSODY: Rationale for and design of a pivotal Phase 3 trial to assess efficacy and safety of rilonacept, an interleukin-1α and interleukin-1β trap, in patients with recurrent pericarditis.
    Klein AL; Imazio M; Brucato A; Cremer P; LeWinter M; Abbate A; Lin D; Martini A; Beutler A; Chang S; Fang F; Gervais A; Perrin R; Paolini JF
    Am Heart J; 2020 Oct; 228():81-90. PubMed ID: 32866928
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.